Physician profile
Jonathan Adams
NPI 1285913970
$1,646.86
in general payments reported to CMS, 2019-2025
20 companies · $39.17 in 2025
The $39.17 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $575 · 2023: $738 · 2024: $76.65 · 2025: $39.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $624.76 | 2021-2024 | Prolia, Evenity, Repatha |
| Abbvie INC. | $214.80 | 2021-2025 | Synthroid, Ubrelvy, Mavyret |
| Pfizer INC. | $133.68 | 2021-2024 | |
| Glaxosmithkline, LLC. | $97.32 | 2021-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $96.07 | 2021-2024 | Jardiance, Emgality, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.36 | 2022-2023 | Jardiance |
| Idorsia Pharmaceuticals US INC | $74.26 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $62.13 | 2021-2022 | |
| Organon LLC | $34.67 | 2023 | Nexplanon, Nuvaring |
| Merck Sharp & Dohme LLC | $33.35 | 2022 | |
| Smith+Nephew, INC. | $32.63 | 2022 | |
| Almatica Pharma LLC | $23.94 | 2022 | |
| Mylan Specialty L.P. | $21.26 | 2022 | |
| Scilex Pharmaceuticals INC. | $19.81 | 2023 | Ztlido |
| Ultragenyx Pharmaceutical INC. | $15.60 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.49 | 2021 | |
| Nevro Corp. | $15.36 | 2023 | Senza |
| Sanofi Pasteur INC. | $15.08 | 2022 | |
| Novo Nordisk INC | $14.88 | 2021 | |
| Esperion Therapeutics, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.